mechanisms of YC-1 and some antiplatelet agents

碩士 === 國立臺灣大學 === 藥理學研究所 === 81 === YC-1 inhibited the aggregation and ATP release of washed rabbit platelets induced by U46619, arachidonic acid, collagen,PAF and thrombin.YC-1 markedly activated guanylate cyclase in platelet homogenate a...

Full description

Bibliographic Details
Main Authors: Wu,Chin-Chung, 吳志中
Other Authors: Teng,Che-Ming
Format: Others
Language:zh-TW
Online Access:http://ndltd.ncl.edu.tw/handle/28838462282747854505
Description
Summary:碩士 === 國立臺灣大學 === 藥理學研究所 === 81 === YC-1 inhibited the aggregation and ATP release of washed rabbit platelets induced by U46619, arachidonic acid, collagen,PAF and thrombin.YC-1 markedly activated guanylate cyclase in platelet homogenate and soluble fraction, and markedly elevated cGMP and cAMP levels in intact platelets. These results suggest that the increase in platelet cAMP caused by YC-1 is mediated by the in- hibition by cGMP of cAMP breakdown, and the antiplatelet effect of YC-1 is likely due to the elevation of both cGMP and cAMP levels. CES-L and Pro-A2 inhibited the rabbit platelet aggrega- tion and ATP release induced by arachidonic acid (AA) and coll- agen, without affecting those induced by U46619,PAF and throm- bin. Thromboxane B2 and prostaglandin D2 formation caused by AA were also suppressed by both antiplatelet agents.CES-L and Pro- A2 inhibited the rise of intracellular calcium concentration caused by AA and collagen, and also suppressed the generation of inositol monophosphate caused by AA,but not that by collagen, U46619, PAF and thrombin.These results suggest that the antipla- telet effect of both CES-L and Pro-A2 is likely due to the inhi- bition of thromboxane A2 formation.